Congratulations! You’ve decided to become a rheumatologist and, in so doing, join the ranks of some of the most intelligent, empathic and dynamic physicians out there. But between your decision today and where you see yourself in three, five or 10 years, many more decisions must be made. Arguably, the most important is the decision…
Over the past few years, biosimilars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options, others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and small molecule inhibitor drugs…
“And of course, I am not telling you to do it. That would be illegal.” As a general rule, I try not to instruct my patients to break the law. My business model depends on repeat customers, so placing a patient at risk of getting arrested—even if that risk is remote—doesn’t seem like a good…
We just learned that Dr. Brown passed away at his home Sunday night, Dec. 1. We are reposting this recent story in his honor. He will be missed.
Increased reimbursement would reflect value of cognitive care and other time-intensive services provided by rheumatologists.
The CMS 2020 Proposed Rule for the Quality Payment Program, released July 29, contains several key changes relevant to MIPS-eligible clinicians.
A recent gene expression analysis found an enriched downstream interferon signature, with predominantly IFNB1 signatures in systemic lupus erythematosus (SLE) patients. The study also found lower expression of all downstream interferon signatures in the kidneys of lupus nephritis patients…
(Reuters Health)—Researchers who examined implicit and explicit gender biases in the U.S. medical community found professionals of both genders are more likely to associate the word career with men and the word family with women. And U.S. surgeons broadly see surgery as a man’s career and family medicine as a woman’s field, the researchers also…
With her combined expertise in rheumatology and informatics, Dr. Yazdany is leading the ACR’s Registries and Health Information Technology Committee to create a national health IT infrastructure that advances rheumatology practice.
CMS estimates that under their proposal, released July 29, rheumatologists would see on average a 15% payment increase, beginning in 2021.